One-pot synthesis of reactive oxygen species (ROS)-self-immolative polyoxalate prodrug nanoparticles for hormone dependent cancer therapy with minimized side effects
Anita Hocherl, Eliézer Jager, Alessandro Jager, Martin Hruby, Rafal Konefal, Olga Janouskova, Jiri Spevacek, Yaming Jiang, Peter W. Schmidt, Timothy P. Lodge, Petr Stepanek
Dive into the research topics of 'One-pot synthesis of reactive oxygen species (ROS)-self-immolative polyoxalate prodrug nanoparticles for hormone dependent cancer therapy with minimized side effects'. Together they form a unique fingerprint.